Abstract
BackgroundSome autoimmune diseases can develop renal manifestations that are refractory to conventional drug treatment, making haemodialysis the only therapeutic alternative.PurposeTo analyse the response rate to rituximab as third-line treatment in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have